文献速递主动脉疾病内脏/肾动脉与血管畸形

烟囱技术择期治疗退行性肾旁主动脉瘤的多中心中期结局

Multicenter Mid-Term Outcomes of the Chimney Technique in the Elective Treatment of Degenerative Pararenal Aortic Aneurysms.
PubMed 文献 · J Endovasc Ther · 2021-10-04

该多中心回顾性研究纳入2008至2014年13个欧美中心267例择期行烟囱腔内修复(CHEVAR)的退行性肾旁主动脉瘤患者,评估其中期结局。结果显示30天死亡率为1.9%,3年原发和继发Ia型内漏/内张力免除率分别为93.0%和98.0%,原发和继发烟囱移植物通畅率分别为87.0%和89.0%,提示择期CHEVAR似乎持久。

要点

  • 择期CHEVAR治疗dPAA的30天死亡率为1.9%,院内并发症率为10.1%。
  • 3年原发和继发Ia型内漏/内张力免除率分别为93.0%和98.0%。
  • 3年原发和继发烟囱移植物通畅率分别为87.0%和89.0%。

核心结论

  • 择期CHEVAR治疗退行性肾旁主动脉瘤似乎持久,结果与其他全腔内策略相当。

研究设计与样本

  • 回顾性分析2008至2014年13个欧洲和美国中心连续267例择期行CHEVAR的dPAA患者。

主要发现

  • 平均随访25.5±13.3个月,涉及442条内脏血管,每例平均烟囱移植物1.63±0.7个。
  • 436条目标血管成功插管,主动脉移植物有意覆盖6条肾动脉,即时技术成功率98.6%。
  • 30天死亡率为1.9%(n=5),院内并发症率10.1%(n=27),包括3例卒中、1例永久透析和1例肠缺血。
  • 未检测到30天Ia型内漏,3.2%的烟囱移植物(n=14,包括有意覆盖)出现闭塞和/或狭窄。
  • CHEVAR相关总死亡率为2.2%(n=6)。

关键数值与推荐

  • 3年原发和继发Ia型内漏/内张力免除率分别为93.0%和98.0%。
  • 原发和继发烟囱移植物通畅率分别为87.0%和89.0%。
  • 3年原发和继发免于任何终点的腔内治疗率分别为81.0%和94.0%。

临床怎么用

  • 择期CHEVAR可用于无症状dPAA患者,中期结局支持其扩展应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Chimney endovascular abdominal aortic aneurysm repair (CHEVAR) has predominantly been described as an alternative technique for the management of urgent presentations of degenerative pararenal aortic aneurysms (dPAAs). However, the role of CHEVAR in the treatment of asymptomatic patients remains unknown. The aim of current multinational study was to evaluate the outcomes of elective CHEVAR of dPAAs. MATERIAL AND METHODS: Retrospective analysis of 267 consecutive dPAA patients treated with elective CHEVAR at 13 European and US centers from 2008 to 2014. Primary endpoints were 30 days and out of hospital CHEVAR-related mortality. Secondary endpoints included persistent type Ia endoleak or endotension, angiographically confirmed occlusion and/or high-grade chimney graft (CG) or involved splanchnic vessel stenosis identified at index procedure and/or during follow-up, as well as CHEVAR-related re-intervention. RESULTS: Mean follow-up time was 25.5±13.3 months. The 442 visceral vessels were involved and mean number of CGs per patient was 1.63±0.7. 436 targeted vessels were successfully cannulated. The aortic graft intentionally covered 6 renal arteries and immediate technical success was 98.6%. The 30 days mortality was 1.9% (n=5), while the in-hospital complication rate was 10.1% (n=27) including 3 strokes, 1 permanent dialysis, and 1 intestinal ischemia. No 30 day type Ia endoleaks were detected and 3.2% of CGs (n=14, including the intentionally covered) had evidence of occlusion and/or stenosis. The overall CHEVAR-related mortality was 2.2% (n=6). Freedom from primary and secondary type Ia endoleak/endotension rates at 3 years was 93.0% and 98.0%, respectively. Primary and secondary CG patency was 87.0% and 89.0%. Primary and secondary endovascular freedom from any endpoint at 3 years was 81.0% and 94.0% respectively. CONCLUSION: Elective use of CHEVAR in the management of dPAAs seems to be durable. These results are comparable to published outcomes with other total endovascular strategies, which justifies an expanded role for CHEVAR in the treatment of asymptomatic patients presenting with dPAAs.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Pitoulias GA, Fazzini S, Donas KP, et al. Multicenter Mid-Term Outcomes of the Chimney Technique in the Elective Treatment of Degenerative Pararenal Aortic Aneurysms. J Endovasc Ther. 2021. PMID: 34605299. doi:10.1177/15266028211047940

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。